Etrolizumab Population Pharmacokinetics (Pop PK) and Covariate Analysis in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

被引：0
|
作者：
Wei, Xiaohui [1 ]
Luca, Diana [1 ]
Wang, Yehong [1 ]
O'Byrne, Sharon [1 ]
Erickson, Rich [1 ]
Davis, John [1 ]
Tang, Meina [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1673
引用
收藏
页码：S496 / S496
页数：1
相关论文
共 50 条
  • [31] LONG-TERM USE OF OZANIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Wolf, Douglas C.
    Colombel, Jean Frederic
    Ponich, Terry P.
    Jovanovic, Igor
    Bossuyt, Peter
    Longman, Randy
    Alekseeva, Olga
    Petersen, AnnKatrin
    Chitkara, Denesh
    Marta, Cecilia
    Charles, Lorna
    Rubin, David T.
    Afzali, Anita
    Loftus, Edward V.
    Danese, Silvio
    GASTROENTEROLOGY, 2022, 162 (07) : S969 - S969
  • [32] COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND USTEKINUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Dubinsky, Marla C.
    Betts, Keith
    Eren, Devrim
    Tang, Wenxi
    Yin, Lei
    Gupte-Singh, Komal
    GASTROENTEROLOGY, 2022, 162 (07) : S603 - S603
  • [33] Long-term use of ozanimod in patients with moderately to severely active ulcerative colitis
    Danese, S.
    Colombel, J-F
    Ponich, T.
    Jovanovic, I.
    Bossuyt, P.
    Longman, R.
    Alekseeva, O.
    Petersen, A. K.
    Marta, C.
    Charles, L.
    Sparrow, M.
    Rubin, D. T.
    Afzali, A.
    Loftus, E. V., Jr.
    Wolf, D. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 125 - 126
  • [34] Etrolizumab as induction and maintenance therapy in patients with moderately to severely active ulcerative colitis: a protocol of systematic review and meta-analysis of placebo-controlled, randomised clinical trials
    Qin, Xuan
    Wang, Menghui
    Zhang, Wei
    Liu, Wenji
    Shu, Hongxin
    Xiong, Xiaowei
    BMJ OPEN, 2024, 14 (01):
  • [35] Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis
    Yuan, William
    Marwaha, Jayson S.
    Rakowsky, Shana T.
    Palmer, Nathan P.
    Kohane, Isaac S.
    Rubin, David T.
    Brat, Gabriel A.
    Feuerstein, Joseph D.
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (05) : 695 - 704
  • [36] Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Xinlin Chen
    Jiangtao Hou
    Yujie Yuan
    Chaoyuan Huang
    Tianwen Liu
    Chuanwei Mo
    Haiwen Li
    Bin Chen
    Qian Xu
    Zhengkun Hou
    Weiling He
    Fengbin Liu
    BioDrugs, 2016, 30 : 207 - 217
  • [37] Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Chen, Xinlin
    Hou, Jiangtao
    Yuan, Yujie
    Huang, Chaoyuan
    Liu, Tianwen
    Mo, Chuanwei
    Li, Haiwen
    Chen, Bin
    Xu, Qian
    Hou, Zhengkun
    He, Weiling
    Liu, Fengbin
    BIODRUGS, 2016, 30 (03) : 207 - 217
  • [38] Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
    Vermeire, Severine
    Lakatos, Peter L.
    Ritter, Timothy
    Hanauer, Stephen
    Bressler, Brian
    Khanna, Reena
    Isaacs, Kim
    Shah, Saumin
    Kadva, Alysha
    Tyrrell, Helen
    Oh, Young S.
    Tole, Swati
    Chai, Akiko
    Pulley, Jennifer
    Eden, Christopher
    Zhang, Wenhui
    Feagan, Brian G.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (01): : 28 - 37
  • [39] Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported Outcomes
    Irani, Malcolm
    Fan, Christopher
    Glassner, Kerri
    Abraham, Bincy P.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2023, 16 : 21 - 28
  • [40] Etrasimod 2mg Once Daily as Treatment for Patients With Moderately to Severely Active Ulcerative Colitis: Topline and Subgroup Analysis From ELEVATE UC 52 and ELEVATE UC 12
    Feagan, Brian G.
    Peyrin-Biroulet, Laurent
    Sandborn, William J.
    D'Haens, Geert
    Panes, Julian
    Yarur, Andres
    Wolf, Douglas C.
    Ritter, Timothy E.
    Schreiber, Stefan
    Sloan, Sheldon
    Cataldi, Fabio
    Shan, Kevin
    Rabbat, Christopher J.
    Chiorean, Michael
    Baert, Filip
    Sands, Bruce E.
    Dubinsky, Marla C.
    Vermeire, Severine
    Goetsch, Martina
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S516 - S517
12345